|
|
⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
Patrice Chevallier
,
Thomas Eugène
,
Nelly Robillard
,
Françoise Isnard
,
Franck Nicolini
et al.
Journal articles
inserm-02913620v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial
Nicolas Boissel
,
Aline Renneville
,
Thibaut Leguay
,
Pascale Cornillet Lefebvre
,
Christian Recher
et al.
Journal articles
inserm-01820455v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Vincent Ribrag
,
Serge Koscielny
,
Jacques Bosq
,
Thibaut Leguay
,
Olivier Casasnovas
et al.
Journal articles
inserm-01419476v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier
,
Jean-Francois Hamel
,
Jacques Delaunay
,
Eric Delabesse
,
Pierre-Yves Dumas
et al.
Journal articles
hal-03604930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study
Arnaud Pigneux
,
Marie C Béné
,
Philippe Guardiola
,
Christian C Recher
,
Jean-Francois Hamel
et al.
Journal articles
inserm-01480651v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
Gregory Segala
,
Marion David
,
Philippe de Médina
,
Mathias Poirot
,
Nizar Serhan
et al.
Journal articles
inserm-02380591v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|